Pre-made Bedinvetmab benchmark antibody ( Canine Whole mAb, anti-Canine NGFB therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Bedinvetmab biosimilar, Canine Whole Mab: Anti-Canine NGFB therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Bedinvetmab is a canine monoclonal antibody (mAb) targeting Nerve Growth Factor (NGF). The inhibition of NGF mediated cell signalling has demonstrated to provide relief from pain associated with osteoarthritis. ... The presence of binding antibodies to bedinvetmab in dogs was assessed using a multitier approach.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-052-1mg	1mg	3090
GMP-Bios-ab-052-10mg	10mg	Inquiry
GMP-Bios-ab-052-100mg	100mg	Inquiry
GMP-Bios-ab-052-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Bedinvetmab biosimilar, Canine Whole Mab: Anti-Canine NGFB therapeutic antibody
INN Name	Bedinvetmab
Target	Canine NGFB
Format	Canine Whole mAb
Derivation	Caninized
Species Reactivity	Canine
CH1 Isotype	IgG2
VD LC	Lambda
Highest_Clin_Trial (Jan '20)	Approved
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2018
Year Recommended	2019
Companies	na
Conditions Approved	na
Conditions Active	Canine lupus familiaris
Conditions Discontinued	na
Development Tech	na